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A B S T R A C T
Objectives: Early-onset preeclampsia is a form of preeclampsia requiring delivery before 34 weeks of
gestation. The etiology is unknown, but placental dysfunction appears crucial. We evaluated the
immunohistochemical expression of the antiapoptotic protein Bcl-2, the angiogenetic factors VEGF and
PlGF, and the epithelial factors HGF, c-Met and STAT3 in placental samples of pregnancies complicated by
early-onset preeclampsia.
Materials and methods: Placental sections were obtained from 41 women with early-onset preeclampsia
(cases) and from 31 uncomplicated pregnancies (controls). A standard haematoxylin and eosin stain was
used to assess histological structure. Immunohistochemical expression of Bcl-2, VEGF, PlGF, HGF, c-Met
and STAT3 was analyzed.
Results: Mean gestational age was 32 weeks in cases and 39 weeks in controls. Microscopically, sections
from women with preeclampsia showed a disorder of villous development as a distal villous hypoplasia
with placental undergrowth. The immunoistochemical expression of Bcl-2 (p < 0.0001), VEGF
(p = 0.0323), PlGF (p = 0.002), HGF (p < 0.0001), c-Met (p < 0.0001) and STAT3 (p = 0.0004) were
signiﬁcantly lower in placentas of complicated pregnancies compared to uncomplicated ones.
Conclusions: Early-onset preeclampsia is associated with a disorder of villous development. Apoptotic,
angiogenetic and epithelial mechanisms are simultaneously impaired and contribute to placental
dysfunctions.
© 2019 Elsevier B.V. All rights reserved.
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Preeclampsia (PE) complicates about 2–8% of pregnancies, and
is a major cause of maternal and perinatal morbidity and mortality
[1]. PE impairs functioning of the kidneys, liver, and central
nervous system [1]. Early preeclampsia is deﬁned by the presence
of a severe form of PE requiring delivery before 34 weeks of
gestation [2]
Although the etiology of PE remains poorly understood [1–30], it
is hypothesized that placental dysfunction may have a crucial role
[31,32]. A common phenomenon observed in PE is the abnormal* Corresponding author at: Department of Neuroscience, Reproductive Sciences
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0301-2115/© 2019 Elsevier B.V. All rights reserved.development and function of the placenta associated with an
abnormal invasion and remodeling of maternal uterine arteries by
extravillous trophoblasts [4]. Apoptotic, angiogenetic and epithelial
mechanisms seem to be involved in placental insufﬁciency.
Exaggerated placental apoptosis is a common feature in PE [5]. B-
cell lymphoma/leukemia (Bcl-2) is speciﬁcally considered as an
important antiapoptotic protein and has been shown to prevent
apoptosis by blocking cytochrome C release from mitochondria [6].
Bcl-2 may be downregulated in placentas from patients with PE [5].
Vascular Endothelial Growth Factor (VEGF) and the Placental
Growth Factor (PlGF) are major factors regulating the placental
angiogenesis for an adequate placental development and function.
Defective action of these angiogenetic factors appears to play a
major role in PE [3].
Epithelial growth factors are also involved in proliferation of
trophoblastic cells. Among these, Hepatocyte Growth Factor (HGF),
its receptor c-Met and the transcriptional factor STAT3 play an
Table 1
Characteristics of study population.
Cases n = 41 Controls n = 31
Gravidity
Median (25-75%; range) 1 (1–2; 1–7) 2 (1–3; 1–4)
Parity
Median (25-75%; range) 0 (0–0; 0–2) 1 (0–2; 0–3)
Gestational age (weeks)
Average  SD 32  2,4 39  1,2
Maternal age (years)
Average  SD (range) 316  4,4 (23–41) 335  1,2 (23–41)
Race%
White n (%) 41 (100) 31 (100)
Ethnicity
Caucasian n (%) 41 (100) 31 (100)
Prenatal medications
Iron n (%) 20 (50) 15 (484)
Vitamine and/or folic acid n (%) 41 (100) 31 (100)
Antihypertensive drugs n (%) 41 (100) 0 (0)
Smoking (before pregnancy)
Cigarettes n (%) 5 (122) 0 (0)
Previous prenatal admission(s)
Yes n (%) 0 (0) 0 (0)
Antibiotics in labor
None n (%) 41 (100) 31 (100)
Beta strep status
Positive n (%) 12 (293) 11 (355)
Antenatal steroids:
Yes n (%) 41 (100) 0 (0)
GA mean  SD 31  2 0 (0)
Magnesium sulfate
Yes n (%) 0 (0) 0 (0)
Anesthesia
Epidural n (%) 41 (100) 31 (100)
Cervical ripening agent
None n (%) 41 (100) 31 (100)
Labor
Yes n (%) 0 (0) 0 (0)
Delivery mode
C-section n (%) 41 (100) 31 (100)
Maternal Oxygen given at delivery?
Yes n (%) 0 (0) 0 (0)
Birth weight (grams)
Average  SD 1541  800 2900  300
Placental weight (grams)
Average  SD 322  103 556  27
Baby’s sex
Female n (%) 25 (61) 18 (581)
Delivery to processing (mins)
Average  SD 30  10,8 30  9
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development [7,8]. HGF is a cytokine that is able to generate, in
cMET expressing cells, the branching morphogenesis that involves
cellular changes in cell shape and cell polarization, cellular
migration and cellular proliferation, creating the tridimensional
branching extension [9]. A defective expression of HGF/c-Met/
STAT3 pathway appears characteristic of organs and placentas
from malformed fetuses [7,8].
The placental expression of antiapoptotic, angionenetic and
epithelial growth factors normally increases during pregnancy
until about 30 weeks with placental development, and then
gradually decreases with placental aging [33,34]. By deﬁnition,
early-onset PE requires delivery before 34 weeks of gestation,
when the activity of these factor should be near its peak. We
hypothesized that such process might be impaired in early-onset
PE, and that the expression of these factor might be lower than in
uncomplicated pregnancies.
The aim of our study is to evaluate the immunohistochemical
expression of Bcl-2, PlGF, VEGF HGF, c-Met and STAT3 in placental
samples from women affected by early-onset PE compared with
uncomplicated pregnancies.
Materials and methods
Study protocol
The study protocol including methods for collection, analysis
and interpretation of data was deﬁned a priori. The study was
designed as a retrospective case-control study and was reported
following the STROBE guidelines [10].
Clinical data of patients were obtained by reviewing medical
records of the Department of Neuroscience, Reproductive
Sciences and Dentistry of the University Federico II, Naples, Italy.
Data about gross and histologic examinations of placental
specimens were retrieved from electronic databases of the
Anatomic Pathology Unit of the Department of Advanced
Biomedical Sciences, University Federico II, Naples, Italy. Paraf-
ﬁn-embedded specimens were retrieved from the archives of the
same unit to perform ad hoc histomorphologic reviews and
immunohistochemical analyses.
Cases
Diagnosis and management of PE was based on ACOG guidelines
[1]. PE was deﬁned as a blood pressure elevation ( 140/90 on two
occasions four hours apart or 160/110 once), after 20 weeks of
gestation, with proteinuria (300 mg on 24 h protein or >0.3 protein/
creatinine ratio) or any of the following if proteinuria not presents:
platelets <100,000; creatinine >1.1 (or doubling of creatinine in
absence of other renal disease); doubling of AST or ALT. PE with severe
features was deﬁned as preeclampsia with any of the following: blood
pressure 160/110 four hours apart on bed rest (unless on antihyper-
tensive);platelets<100,000; doublingof ASTorALT; creatinine>1.1(or
doubling of creatinine in absence of other renal disease); pulmonary
edema; new cerebral or visual disturbances. Early-onset PE was
deﬁned as PE requiring delivery before 34 weeks of gestation.
For this study we included women with singleton gestations
and with early-onset PE without fetal malformations. We included
all consecutive cases from March 2009 to April 2011
We selected as cases only women affected by early-onset
PE, since it is considered as a distinct disease from late-onset PE [1],
and is characterized by higher risk of fetal and perinatal morbidity/
mortality [2]. To understand whether HGF/c-Met/STAT3 pathway
deﬁciency characterizes PE independently from fetal malforma-
tions, we included in our study only placentas from fetuses
without major congenital malformations.Controls
Controls were low-risk pregnant women with uncomplicated
singleton gestations. Intrauterine growth restriction (IUGR),
chronic hypertension, diabetes, renal diseases were excluded.
Controls were randomly selected in the same period as the cases.
For both cases and controls, gestational age had been assessed
by the last menstrual period and conﬁrmed by ultrasound.
Placental specimens
Placentas had been collected after a caesarean section and ﬁxed
for 24 h in 4% phosphate-buffered formaldehyde (Ph 7.2). Weight
and diameter had been measured for each specimen; umbilical
cord and membranes were removed before weight measurement.
Sampling protocol included seven full-thickness section of the
chorionic plate (four central, approximately equally spaced, and
three peripheral), two sections of the membranes and two sections
of the cord. After that, the tissues had been embedded in parafﬁn
(melting point 52 C); 4 mm parafﬁn sections had been mounted on
glass slides covered with 3-amino-propyl–ethoxy3 silane (Sigma,
Fig. 1. Alteration of morphology of chorionic villi in women with early
preeclampsia: accelerated maturation (A) and immaturity (B).
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stain had been used to assess histological structure.
Immunohistochemistry
Immunohistochemistry was carried with polyclonal rabbit anti-
bodies against: HGFα (H-145, sc-7949, 200mg/ml, 1:50, Santa Cruz
Biotechnology, Santa Cruz CA), c-Met (B-2, sc-8057, 200mg/ml, anti h-
met, 1:50, Santa Cruz Biotechnology), STAT3 (h-190, sc-7179, 200mg/
ml, 1:50, Santa Cruz Biotechnology), VEGF (A-20, sc-152, 100mg/ml,
1:200, Santa Cruz Biotechnology, recommended for 189, 165 and 121
amino acid splice variants of VEGF-A), PlGF (C-20, sc-1880, 200mg/ml,
1:50, Santa Cruz Biotechnology), and mouse monoclonal antibody
against Bcl-2 (124, M0887, 200mg/ml, 1:100, DAKO).
Brieﬂy, sections were deparafﬁnised with xylene, rehydrated
through a graded series of ethanol solutions to distilled water, PBS
(phosphate buffered saline) was used for all subsequent washes and
for antiserum dilution. Tissue sections were treated sequentially in
0.3% hydrogen peroxide absolute methanol for 30 min to quench
the endogenous peroxidase activity. Slides were then incubated at
4 C overnight. After three washes in PBS to remove the excess of
antiserum, the slides were incubated with goat anti-rabbit
biotinylated antibodies (Vector laboratories, Burlingame CA, U.S.
A.) at 1:200 dilution in PBS 3% for 1 h, all slides were then processed
by the ABC method (Vector laboratories) for 30 min at room
temperature. Diaminobenzidine (Vector Laboratories) activated
with 0.05% hydrogen peroxide was used as ﬁnal chromogen and
Mayer’s haematoxylin was used as the nuclear counterstaining.
Negative controls for each tissue sections were prepared by leaving
out the primary antiserum and replacing it with normal rabbit
serum. Positive controls were represented by vascular tumor
(angioma), breast carcinoma, colon carcinoma. All samples were
processed under the same conditions. Immunocytochemical
evaluation was performed by localization (epithelial, endothelial
mesenchymal) and by quantiﬁcation of reactivity.
Analysis and interpretation of data
The main outcome considered was the immunohistochemical
expression of Bcl-2, PlGF, VEGF HGF, c-Met and STAT3 in the
placental specimens.
The markers expression was dichotomized into negative or
positive, based on the number of reactive cells < or >10%
respectively, from observation of 10 ﬁelds using 40x magniﬁcation.
Intensity of immunohistochemical staining was scored as follows:
0 = complete absence of staining; 1 = weak intensity of staining; 2 =
moderate intensity of staining; 3 = strong intensity of staining.
Histological and immunocytochemical evaluation were per-
formed independently by an expert perinatal pathologist (MDA)
and a second pathologist (AT), who were blinded to clinical data.
Disagreements were resolved by discussion at a two-headed
microscope.
Univariate comparisons between cases and controls were
performed by using Fisher's exact test for two-tailed P value with
α = 0.05 signiﬁcance level.
Statistic analysis were performed using SPSS 17.0 package (SPSS
Inc., Chicago, IL, USA).
Results
Characteristics of women
Forty-one women were included in the cases group and 31 in
the control group.
In cases and controls, the mean maternal age was 31.6  4.4
years (range: 23–41) and 33.5 1.2 years (range: 23–41), thegestational age was 32  2.4 weeks and 39  1.2 weeks, the median
gravidity was 1 (range: 1–7) and 2 (range: 1–4), the median parity
was 0 (range: 0–2) and 1 (range: 0–3), respectively. All women
were white and Caucasian. Among cases and controls, only 5 cases
(12.2%) were smokers prior to pregnancy. All women delivered by
cesarean section and no newborns presented malformations.
Characteristics are reported in detail in Table 1, according to
Nelson et al. [12].
Characteristics of placentas
In cases and controls, placental weight was 322  103 and
556  27 g and placental diameter was 12  2 and 18  2 cm,
respectively.
Microscopically, all cases showed a disorder of villous
development as a distal villous hypoplasia with placental
undergrowth (Fig. 1). The distal villi were decreased especially
in the center of the placental lobule. Residual distal villi were
sparse, thin, non-branching, poorly vascularized, with focal
increase in the number of syncytial knots (Tenney-Parker change).
The tertiary stem villi were prominent at the periphery of the
lobule, they showed increased stromal collagen, muscular
hypertrophy of arterioles, intervillous ﬁbrin and villous agglutina-
tion. There was focal hypertrophic decidual vasculopathy.
On the other hand, no morphologic abnormalities were
observed in controls’ placentas.
Immunohistochemical ﬁndings
Where positive, the expression of VEGF, PlGF and Bcl-2 was
localized in cytotrophoblastic cells. Negative expression of VEGF,
PlGF and Bcl-2 was observed in 14 (34.1%), 19 (46.3%) and 33
(80.5%) cases respectively, and in 3 (9.7%), 3 (9.7%) and 0 (0%)
controls respectively. Negative expression was signiﬁcantly more
Fig. 2. Immunohistochemical expression of: Bcl-2 in cases (A, 100X) and controls (B, 40X); VEGF in cases (C, 40X) and controls (D, 40X); PlGF in cases (E, 40X) and controls (F,
40X); HGF in cases (G, 100X) and controls (H, 200X); c-Met in cases (I, 200X) and controls (L, 200X); STAT3 in cases (M, 40X) and controls (O,100X).
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Table 2
Immunohistochemical expression of HGF, c-Met, Stat3, Bcl-2, VEGF, PlGF in cases
and controls.
Marker Negative expression p-value
Cases n (%) Controls n (%)
Bcl-2 33 (805) 0 (0) <0.0001
VEGF 14 (341) 3 (9.7) 0.0323
PlGF 19 (463) 3 (9.7) 0.002
HGF 27 (65.8) 1 (3.2) <0.0001
c-Met 26 (63.4) 1 (3.2) <0.0001
Stat3 29 (707) 8 (25.8) 0.0004
204 A. Travaglino et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 234 (2019) 200–206common in cases than in controls for all markers (VEGF p = 0.0323;
PlGF p = 0.002; Bcl-2 p < 0.0001)
Where positive, the expression of HGF, c-Met and STAT3 was
localized in the cytoplasm of epithelial cells, ﬁbroblast and
myoﬁbroblast cells. Negative expression of HGF, c-Met and STAT3
was observed in 27 (65.8%), 26 (63.4%) and 29 (70.7%) casesTable 3
Intensity of immunohistochemical expression of HGF, c-Met, Stat3, Bcl-2, VEGF, PlGF in
CONTROLS C
N Bcl -2 VEGF PlGF HGF c-
Met
STAT3 N Bcl -2 VEGF P
1 2 3 2 3 2 3 1 2 3
2 3 2 3 3 2 2 2 2 2
3 3 2 3 2 3 1 3 2 2
4 3 3 3 3 2 1 4 0 2
5 3 3 3 3 2 1 5 0 2
6 2 2 2 3 2 2 6 1 1
7 2 2 3 2 3 2 7 2 1
8 3 2 3 3 3 3 8 0 1
9 3 3 3 3 3 2 9 1 2
10 2 2 2 3 2 2 10 0 1
11 2 2 3 3 2 3 11 1 2
12 2 2 3 3 2 2 12 0 3
13 3 2 3 3 2 2 13 1 1
14 3 3 2 3 3 2 14 2 1
15 2 2 2 2 2 1 15 0 3
16 2 3 2 2 2 2 16 1 1
17 3 3 2 3 2 3 17 1 2
18 3 1 3 3 2 1 18 1 1
19 2 1 3 2 2 2 19 1 1
20 2 2 3 2 2 2 20 1 3
21 2 1 3 2 2 1 21 2 2
22 2 3 0 3 3 3 22 2 2
23 3 3 0 2 2 2 23 0 1
24 3 3 1 3 2 2 24 0 2
25 2 1 3 3 2 3 25 0 1
26 3 2 2 2 3 2 26 0 2
27 3 2 2 2 2 2 27 1 2
28 2 1 3 3 3 2 28 1 2
29 3 2 3 2 3 1 29 0 2
30 2 2 3 3 3 2 30 1 3
31 2 3 3 1 1 1 31 0 3
32 1 2
33 0 2
34 1 1
35 1 3
36 0 3
37 2 2
38 0 3
39 1 1
40 0 1
41 1 2respectively, and in 1 (3.2%), 1 (3.2%) and 8 (25.8%) controls
respectively. Negative expression was signiﬁcantly more common
in cases than in controls for all epithelial markers (HGF p < 0.0001;
c-Met p < 0.0001; STAT3 p = 0.0004) (Fig. 2).
Immunohistochemicalﬁndings are summarizedinTables2 and3.
As expected, signiﬁcant direct correlation was observed
amongst epithelial factors (HGF, c-Met and STAT3); Bcl-2 and
PlGF directly correlated with epithelial factors as well. Signiﬁcant
inverse correlation was found between the two angiogenic factors
VEGF and PlGF (Table 4).
Discussion
Our study showed that a concomitant alteration in the
expression of apoptotic, angiogenetic and epithelial factors is
involved in placental dysfunctions underlying PE, independently
from fetal malformations and with speciﬁc regard to early-onset
PE. each case and control.
ASES
lGF HGF c-
Met
STAT3
1 0 1 1
3 2 2 2
2 3 2 3
2 3 2 2
1 0 1 0
3 3 2 2
2 3 2 3
1 0 0 0
0 0 1 1
2 1 1 1
1 0 1 1
1 0 1 1
3 3 2 3
2 1 2 2
1 0 1 1
2 2 1 1
1 2 1 1
2 1 1 1
2 1 1 1
1 0 1 1
3 2 2 2
2 2 2 1
2 2 2 2
1 1 1 1
2 2 1 1
2 1 1 1
2 1 1 1
2 2 2 2
2 1 1 2
1 1 2 1
0 0 0 0
2 1 2 1
0 0 0 0
2 2 2 1
1 1 1 1
1 0 1 1
1 1 2 2
0 0 1 1
2 1 1 1
1 1 1 1
1 1 1 1
Table 4
P-values of the statistical association amongst the markers assessed.
Bcl-2 VEGF PlGF HGF c-Met STAT3
Bcl-2 - 0.6925 0.2488 0.0966 0.0018 * 0.0042 *
VEGF 0.6925 - 0.0038 ** 0.1703 0.4816 0.7186
PlGF 0.2488 0.0038 ** - 0.0003 * 0.0028 * 0.002*
HGF 0.0966 0.1703 0.0003 * - 0.0001 * 0.0008 *
c-Met 0.0018 * 0.4816 0.0028 * 0.0001 * - <0.00001*
STAT3 0.0042 * 0.7186 0.002* 0.0008 * <0.00001* -
*: signiﬁcant direct correlation; **: signiﬁcant inverse correlation.
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placenta, and this condition may induce apoptosis in trophoblastic
cells. This hypoxia-induced apoptosis is accompanied by decreased
expression of Bcl-2. Increased apoptosis together with decreased
invasion and migration ability of trophoblast cells in the placenta
have been proposed as a major causes of PE [5].
Endothelial dysfunction, caused by suppression of VEGF
signaling, also seems to be a major factor involved in PE. VEGF
and PlGF are angiogenetic factor which promote pseudovasculo-
genesis, i.e. the transformation on cytotrophoblast from an
epithelia into an endothelial phenotype. Secretion of VEGF and
PlGF is normally induced in trophoblast cells. In PE, increased level
of the soluble fms-like tyrosine kinase 1 (sFlt-1) led to a
suppression of VEGF and PlGF signalling, which may partially
explain the vascular remodeling disorder described in patients
with preeclampsia. Circulating levels of PlGF have been found
decreased in women with severe preeclampsia comparing with
normotensive pregnant [3].
Regarding epithelial factors, the cascade of HGF/c-Met/STAT3
plays a key role in proliferation and morphogenesis of many cells
and tissues, including trophoblast. HGF is a pleiotropic mesen-
chyme-derived cytokine produced by ﬁbroblasts and in general by
mesenchymal cells, promoting hepatocyte proliferation in vitro
[13]. HGF, binding c-Met, leads to dimerization, autophosphor-
ylation and transient association of the receptor with cytoplas-
matic STAT3 protein. This association induces STAT3
phosphorylation followed by translation to the nucleus [14].
STAT3 induces branching formation, cell migration, cell prolifera-
tion and morphogenesis of the trophoblast [15,16]. Also, it has been
demonstrated that insufﬁcient HGF production leads to kidney
ﬁbrosis [17]. Preeclampsia is associated with characteristic
glomerular lesions, known as glomerular endotheliosis, and it
appears that proteinuria in PE is the result of direct injury to renal
podocytes [18]. Thus, it is presumable that HGF/cMet may play a
role in the renal dysfunction of patients with PE.
In our series, all the studied factors showed a signiﬁcantly lower
expression in complicated pregnancies than uncomplicated ones.
This result appears even more interesting if we consider that the
expression of these molecules gradually decreases after about 30
weeks with placental aging, and thus it should have been higher in
cases (mean gestational age = 32 weeks) than in controls (mean
gestational age = 39 weeks). Also the placental morphology
showed important differences between the two groups: cases
showed a disorder of villous development as a distal villous
hypoplasia with placental undergrowth, while the controls
showed no abnormalities. Placenta with distal villous hypoplasia
is unable to absorb oxygen. This pathologic aspect could result in
placental dysfunction and abnormal feto-maternal ﬂows [19].
Our sample may be the largest in the literature assessing c-Met
and STAT3, and the second largest assessing HGF [20]. Moreover,this is the largest study evaluating c-Met, STAT3 and HGF
speciﬁcally in early-onset PE (<34 weeks), which is considered
as a condition distinct from late-onset PE [2].
To our knowledge, our study is the ﬁrst to assess all these
apoptotic, vascular and epithelial factors together, showing that
the three mechanisms are simultaneously involved in the placental
dysfunction underlying PE. Such a ﬁnding is consistent with
scientiﬁc evidence on the interactions between these factors.
Indeed, VEGF can inhibit apoptosis by inducing expression of Bcl-2
[21], and STAT3 protein is also implicated in the regulation of VGFR
expression [22].
Another strength of our study was the collection of the analyzed
tissues. In fact, the investigated cases included no malformed
fetuses’ placentas in pregnancies complicated by early-onset PE.
This allowed to eliminate a possible confounding factor, as
deﬁciency of HGF/c-Met/STAT3 pathway has been shown in
organs and placentas from malformed fetuses [7,8].
On the other hand, the major limitation of our study may be the
lack of matching between cases and controls with regard to some
characteristics, e.g. gestational age. However, as discussed above,
the difference in the gestational age should not affect our results,
but rather it might even strengthen them.
Further studies are necessary to clarify etiopathogenetic
mechanisms underlying early-onset PE, and to eventually identify
novel diagnostic and therapeutic targets.
Conclusion
Early-onset PE is associated with a disorder of villous
development, as a distal villous hypoplasia with placental
undergrowth. Apoptotic, angiogenetic and epithelial mechanisms
are simultaneously involved in placental dysfunctions underlying
early-onset PE, as the expression of Bcl-2, PlGF, VEGF HGF, c-Met
and STAT3 appeared signiﬁcantly decreased in placentas from
women with preeclampsia. Such association is independent from
fetuses’ malformations.
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